Sonic Healthcare Ltd
SHL
Company Profile
Business description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
Contact
225 George Street
Level 22, Grosvenor Place
SydneyNSW2000
AUST: +61 298555444
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2025
Employees
9,954
Stocks News & Analysis
stocks
What we think of the 3 big winners of the ASX 100
Exploring the ASX companies who dominated the market this year
stocks
Ask the analyst: Why have Healius shares struggled so much?
Shares in Australia's second biggest pathology operator have floundered in recent years. Shane Ponraj thinks better days could be ahead.
personal-finance
Top 8 ASX dividend shares
These undervalued shares with moats have attractive and potentially growing dividends.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,053.20 | 142.30 | -1.74% |
CAC 40 | 7,781.34 | 134.74 | -1.70% |
DAX 40 | 22,068.94 | 392.58 | -1.75% |
Dow JONES (US) | 41,583.90 | 715.80 | -1.69% |
FTSE 100 | 8,559.05 | 99.80 | -1.15% |
HKSE | 23,119.58 | 307.02 | -1.31% |
NASDAQ | 17,322.99 | 481.04 | -2.70% |
Nikkei 225 | 35,617.56 | 1,502.77 | -4.05% |
NZX 50 Index | 12,270.00 | 17.46 | -0.14% |
S&P 500 | 5,580.94 | 112.37 | -1.97% |
S&P/ASX 200 | 7,843.40 | 138.60 | -1.74% |
SSE Composite Index | 3,335.75 | 15.56 | -0.46% |